middle.news
Why Did NeuroScientific’s Loss Balloon to $1.85M After StemSmart™ Acquisition?
2:56am on Saturday 30th of August, 2025 AEST
•
Healthcare
Read Story
Why Did NeuroScientific’s Loss Balloon to $1.85M After StemSmart™ Acquisition?
2:56am on Saturday 30th of August, 2025 AEST
Key Points
Net loss of $1.85 million for FY25, reversing prior year profit
Acquisition of Isopogen WA Ltd completed, adding StemSmart™ platform
Initiation of Special Access Scheme for fistulising Crohn’s disease patients
Strong cash position of $7.27 million supports ongoing R&D activities
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Neuroscientific Biopharmaceuticals (ASX:NSB)
OPEN ARTICLE